Nuwellis FCF Yield

What does Nuwellis do? Nuwellis, Inc. develops, manufactures, and commercializes medical devices for ultrafiltration therapy, primarily the Aquadex SmartFlow and Aquadex FlexFlow systems. The Aquadex System includes a console with electromechanical pumps and an LCD screen, a disposable blood circuit set, and a catheter. It targets patients with fluid overload unresponsive to diuretics, indicated for adult and pediatric use from 20 kilograms. Hospitals and healthcare providers purchase these systems to manage fluid overload in patients who have failed diuretic therapy. The company focuses on selling the Aquadex System as a comprehensive solution for ultrafiltration therapy. Nuwellis markets the Aquadex SmartFlow system specifically for temporary or extended use in patients with fluid overload unresponsive to medical management. The Aquadex FlexFlow system is part of the same product line, designed for similar therapeutic applications. The company's revenue comes from the sale of the Aquadex System components, including the console, disposable blood circuit sets, and catheters. Healthcare facilities are the primary buyers, using these devices to treat patients requiring ultrafiltration therapy. The Aquadex System is positioned as a medical device solution for fluid overload cases where diuretics have failed. It consists of a console, disposable blood circuit set, and catheter, all sold together as a system. Hospitals and clinics purchase the Aquadex System to provide treatment options for patients who cannot be managed with standard diuretic therapy. The company's revenue model relies on the sale of the complete system and its disposable components to healthcare providers. Nuwellis is one of the most popular companies on Eulerpool.